Skip to content
Screener

Teleflex TFX EMEA — Research and development expenses

Other segment segments

Americas
$12.98M+13.1%
Asia
$3.51M-29.3%

Similar metrics at other companies

Titan International logo
TWIConsumer — Research and development expenses
$1.01M+13.3%
Titan International logo
TWIAgriculture — Research and development expenses
$1.49M+9.7%
Baxter International logo
BAXPharmaceuticals — Research and development expenses
$22M-15.4%
CNH Industrial N.V. logo
CNHAgriculture — Research and development expenses
$205M+25.8%
CNH Industrial N.V. logo
CNHConstruction — Research and development expenses
$27M+28.6%
Kratos Defense & Security Solutions logo
KTOSUS — Research and development expenses
$800K+100%

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$6.15B+24.1%
Enterprise value$8.81B+31.7%
P/S2.7×-0.1×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%—

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity1×+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemAmericasEMEAAsiaSegment Total
Net revenues$348,838$145,531$75,963$570,332
Cost of goods sold116,52056,02530,926203,471
Research and development expenses12,97626,3333,50942,818
Selling, general and administrative expenses77,05654,78026,514158,350
Segment operating profit (1)$142,286$8,393$15,014$165,693

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's EMEA — research and development expenses?
Teleflex (TFX) reported EMEA — research and development expenses of $26.33M in Q2 2026.
How has Teleflex's EMEA — research and development expenses changed year-over-year?
Teleflex's EMEA — research and development expenses increased by 236.1% year-over-year, from $7.84M to $26.33M.
What is the long-term trend for Teleflex's EMEA — research and development expenses?
Over 3 years (2022 to 2025), Teleflex's EMEA — research and development expenses has grown at a -4.2% compound annual growth rate (CAGR), from $69.82M to $61.48M.
What does EMEA — research and development expenses mean?
Captures the investment in innovation and product development specifically allocated to the EMEA segment's portfolio. These expenditures support the creation of new medical technologies and the improvement of existing product lines to maintain market relevance. Higher investment levels often signal a commitment to long-term product pipeline growth and competitive differentiation.

Ask your AI about Teleflex's emea — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude